Predicting 5-Fluorouracil Effectiveness in Tumors Using MRS
Author Information
Author(s): P.M.J. McSheehy, M.J.W. Prior, J.R. Griffiths
Primary Institution: CRC Biomedical Magnetic Resonance Research Group, Department of Biochemistry, St George's Hospital Medical School
Hypothesis
Can the levels of fluoronucleotides formed from 5-fluorouracil (5FU) predict its cytotoxicity in the Walker carcinosarcoma?
Conclusion
The study found that MRS-detectable changes in tumor fluoronucleotide levels can predict the cytotoxicity of 5-fluorouracil.
Supporting Evidence
- 50 mg/kg of 5FU caused significant tumor growth inhibition.
- 25 mg/kg of 5FU produced less tumor fluoronucleotides and did not cause significant tumor regression.
- Combination of 50 mg/kg of 5FU with allopurinol significantly suppressed tumor regression.
Takeaway
Researchers used a special imaging technique to see how a cancer drug works in tumors, and they found that higher levels of certain chemicals in the tumors meant the drug was more effective.
Methodology
The study involved administering different doses of 5FU to rats with Walker carcinosarcoma and measuring the resulting levels of fluoronucleotides using magnetic resonance spectroscopy.
Limitations
The study was conducted in rats, which may not fully represent human responses to 5FU treatment.
Participant Demographics
Female Wistar rats weighing 180-200g were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website